News
Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and ...
In a report released today, Gena Wang from Barclays maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a price target of ...
The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and sent Wall Street into a frenzy of concern over the future of biopharma approvals in the near term.
Passengers aboard a Delta Air Lines flight evacuated on emergency slides onto the Orlando International Airport tarmac in Florida on Monday after an engine fire. The Federal Aviation ...
Google Slides on the web is getting a rather notable addition with a new right sidebar that provides quick access to creative tools, including some new ones. This new sidebar shows three groupings ...
Tesla’s sales are continuing to slide in California. According to the California New Car Dealers Association, Tesla registrations are down 15% in Q1 2025. California is the most important market ...
Every year, thousands of tonnes of brown algae are extracted from the seabed to obtain compounds such as alginates, a polymer composed of sugars that has high density and strength, offering ...
and a wonderful example of the power of biotechnology to protect species, both extant and extinct.” Drew Weisholtz is a reporter for TODAY Digital, focusing on pop culture, nostalgia and ...
One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.
Evaxion Biotech (EVAX) shares fell over 25% premarket on Thursday after the company priced an offering to raise $10.8M. The sale comprises 3,997,361 of the company's American Depositary Shares and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results